MX2025001366A - Capsulas de gel blando de disolucion rapida - Google Patents

Capsulas de gel blando de disolucion rapida

Info

Publication number
MX2025001366A
MX2025001366A MX2025001366A MX2025001366A MX2025001366A MX 2025001366 A MX2025001366 A MX 2025001366A MX 2025001366 A MX2025001366 A MX 2025001366A MX 2025001366 A MX2025001366 A MX 2025001366A MX 2025001366 A MX2025001366 A MX 2025001366A
Authority
MX
Mexico
Prior art keywords
fast dissolving
softgel capsules
softgel
film
capsules
Prior art date
Application number
MX2025001366A
Other languages
English (en)
Spanish (es)
Inventor
Soo Ah Jin
Qi Fang
Karunakar Sukuru
Aris Gennadios
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of MX2025001366A publication Critical patent/MX2025001366A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2025001366A 2022-08-12 2025-01-31 Capsulas de gel blando de disolucion rapida MX2025001366A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263397554P 2022-08-12 2022-08-12
PCT/US2023/030042 WO2024035911A1 (en) 2022-08-12 2023-08-11 Fast dissolving softgel capsules

Publications (1)

Publication Number Publication Date
MX2025001366A true MX2025001366A (es) 2025-03-07

Family

ID=89852410

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025001366A MX2025001366A (es) 2022-08-12 2025-01-31 Capsulas de gel blando de disolucion rapida

Country Status (13)

Country Link
US (1) US20250057774A1 (cg-RX-API-DMAC10.html)
EP (1) EP4568657A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025527331A (cg-RX-API-DMAC10.html)
KR (1) KR20250047815A (cg-RX-API-DMAC10.html)
CN (1) CN119907662A (cg-RX-API-DMAC10.html)
AR (1) AR130185A1 (cg-RX-API-DMAC10.html)
AU (1) AU2023321676A1 (cg-RX-API-DMAC10.html)
CA (1) CA3263875A1 (cg-RX-API-DMAC10.html)
CO (1) CO2025002953A2 (cg-RX-API-DMAC10.html)
MX (1) MX2025001366A (cg-RX-API-DMAC10.html)
TW (1) TW202408464A (cg-RX-API-DMAC10.html)
UY (1) UY40394A (cg-RX-API-DMAC10.html)
WO (1) WO2024035911A1 (cg-RX-API-DMAC10.html)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60238269D1 (de) * 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
JP5572086B2 (ja) * 2008-04-02 2014-08-13 株式会社林原 ソフトカプセル皮膜及びソフトカプセル
CN103228269B (zh) * 2010-08-04 2015-06-17 R·P·舍勒科技有限责任公司 软胶囊用成膜组合物
EP2689774B1 (en) * 2011-03-21 2019-01-30 Broda Technologies Co., Ltd Reversely thermo-reversible hydrogel compositions
JP6389237B2 (ja) * 2013-03-15 2018-09-12 パセオン ソフトジェルズ インコーポレイティド 非ゼラチン性腸溶性軟質カプセル
CN103495176B (zh) * 2013-10-26 2015-01-28 中山市凯博思淀粉材料科技有限公司 一种共混挤出法制备淀粉基软胶囊的方法
CN105434397B (zh) * 2015-12-31 2018-06-29 厦门金达威生物科技有限公司 一种植物性软胶囊胶皮组合物及其制备方法
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
KR20220080130A (ko) * 2019-10-09 2022-06-14 알.피.쉐러 테크놀러지즈 엘엘씨 비-동물 소프트겔 캡슐 제제, 그의 제조 방법 및 사용 방법
CN110898028A (zh) * 2019-12-23 2020-03-24 汤臣倍健股份有限公司 一种组合物及其软胶囊囊壳
CN113332257B (zh) * 2021-06-28 2023-05-05 仙乐健康科技股份有限公司 软胶囊囊壳和软胶囊
JP2024525543A (ja) * 2021-07-06 2024-07-12 アール.ピー.シェーラー テクノロジーズ,エルエルシー 軟質ゲルカプセル剤
CN114028357A (zh) * 2021-09-28 2022-02-11 山东弥美生物科技股份有限公司 一种普鲁兰多糖软胶囊及其制备方法

Also Published As

Publication number Publication date
CO2025002953A2 (es) 2025-03-27
WO2024035911A1 (en) 2024-02-15
US20250057774A1 (en) 2025-02-20
WO2024035911A9 (en) 2024-12-26
EP4568657A4 (en) 2026-08-05
TW202408464A (zh) 2024-03-01
UY40394A (es) 2024-02-15
CA3263875A1 (en) 2024-02-15
AR130185A1 (es) 2024-11-13
JP2025527331A (ja) 2025-08-20
EP4568657A1 (en) 2025-06-18
AU2023321676A1 (en) 2025-03-20
CN119907662A (zh) 2025-04-29
KR20250047815A (ko) 2025-04-04

Similar Documents

Publication Publication Date Title
JP5068401B2 (ja) Hpmcカプセルを使用する腸及び結腸への送達
ES2582942T3 (es) Composiciones farmacéuticas de liberación controlada que comprenden un éster de ácido fumárico
CN102824333B (zh) 一种口腔速溶膜剂及其制备方法
RU2008151949A (ru) Фармацевтические лекарственные формы и композиции фенилэфрина для абсорбции в ободочной кишке
CN102149369A (zh) 卡比多巴/左旋多巴胃滞留给药
JP2008519075A (ja) 非ゼラチン軟質カプセルシステム
KR930700077A (ko) 서방성 약제 제형물
PT85049B (pt) Processo para a preparacao de uma combinacao de libertacao controlada, de carbidopa/ levodopa
MX2022003883A (es) Formulaciones en capsulas de gel blando de origen no animal, metodos de preparacion y metodos de uso de las mismas.
US20160074331A1 (en) Composite structural material and pharmaceutical composition thereof
JP2021524477A (ja) 自己調節性の浸透性胃保持性薬物送達システム
PT85591B (pt) Processo para a preparacao de composicoes farmaceuticas sob a forma de dose unitaria-multipla contendo l-dopa
CA2625554A1 (en) Enteric soft capsule comprising valproic acid
EP3866758B1 (en) Softgels with solid or gel-like polymeric fill matrix
CN113476421A (zh) 一种非布司他的控释组合物及其制备方法
WO2005063219A2 (en) Ibuprofen-containing soft gelatin capsules
CN119139260A (zh) 含阿司匹林的药物制剂及其制备方法和应用
Bajpai et al. Design and in vitro evaluation of compression-coated pulsatile release tablets of losartan potassium
CN105663096A (zh) 一种沃诺拉赞口腔速溶膜剂及其制备方法
Fieve et al. Follow-up studies of lithium and thyroid function in manic-depressive illness
US8927025B2 (en) Alcohol-resistant metoprolol-containing extended-release oral dosage forms
CA2965256A1 (en) Novel pharmaceutical formulation
CO2025002953A2 (es) Cápsulas blandas de disolución rápida
TW200800155A (en) Gastric retentive gabapentin dosage forms and methods for using same
WO2021146016A1 (en) Sustained release compositions comprising liothyronine